Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study
PaperCitations, authors & open-access status
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 161 citations, 2021 year and green oa status.
161
Citations
2021
Year
green
OA Status